C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2002
12/25/2002	CN1387521A Process for producing benzylamine compound
12/25/2002	CN1387520A Process for preparing N-(4-hydroxy-phenyl)-N'-(4'-aminophenyl)-piperrazine
12/25/2002	CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity
12/24/2002	US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002	US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002	US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis
12/24/2002	US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
12/24/2002	US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	CA2280994C O-demethylation of pharmaceutical intermediates using microorganism of the genus monosporium or thamnostylum
12/20/2002	WO2002000259A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
12/20/2002	CA2413506A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100848A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100536A1 Method for hydrogenating organic compounds by means of ru/sio2 catalysts
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002080161A3 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
12/19/2002	WO2002070541A3 Peptide deformylase inhibitors
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193383 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	CA2450271A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450077A1 Method for hydrogenating organic compounds by means of ru/sio2 catalysts
12/19/2002	CA2449948A1 Methods of treating alzheimer's disease
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002	EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
12/18/2002	EP1265850A2 Insecticidal anthranilamides
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265844A1 Method for producing amines by the hydroaminomethylation of olefins in the presence of ionic liquids
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1114026B1 Method for simultaneously producing a cyclic lactam and a cyclic amine
12/18/2002	EP0891344B1 Alpha-1 adrenergic receptor antagonists
12/18/2002	EP0859607B1 Guanidino protease inhibitors
12/18/2002	EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002	CN1385421A Novel alpha-amino acid compound, its preparation process and medicinal composition contaiing same
12/18/2002	CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002	US6495720 Preparing trisubstituted hydroxylamines, obtained from nitroxides, which can be used in particular as radical-polymerization initiators
12/17/2002	US6495715 Calcium channel blockers
12/17/2002	US6495546 Propanolamine derivatives
12/12/2002	WO2002098872A1 Isoindolines and process for preparation thereof
12/12/2002	WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002	WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	WO2002098844A1 Method for producing perfluoroalkanesulfonic acid esters
12/12/2002	WO2002098843A2 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
12/12/2002	WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002098406A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	WO2002098367A2 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
12/12/2002	WO2002074756A3 Urokinase inhibitors
12/12/2002	WO2002066415A3 Non-steroidal modulators of estrogen receptors
12/12/2002	US20020188130 Alpha, alpha-dibromo-alpha-chloro-acetophenones as synthons
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020187992 Prodrugs via acylation with cinnamate
12/12/2002	US20020187928 Phosphinylmethyl and phosphorylmethyl succinic and glutauric acid analogs as B-secretase inhibitors
12/12/2002	DE10128242A1 Hydrogenation of organic compounds e.g. aromatic amines or phenols, by using hydrogen in presence of catalyst comprising ruthenium on amorphous silicon dioxide based carrier
12/12/2002	CA2449060A1 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2443850A1 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
12/11/2002	EP1264828A1 New inhibitor of urokinase
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263860A1 New 3-arylbenzofuranones with electron-withdrawing substituents as stabilizers
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0920456B1 Phosgenated oxime resins and their preparation
12/11/2002	EP0907632B1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
12/11/2002	CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/11/2002	CN1384102A Alkyl alcohol piperazine derivative and its application in preparing medicine for treating depression
12/10/2002	US6492555 Reaction of a carbamate with either a (s)-secondary alcohol or (s)-epoxide or (s)-ester; bactericides
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492547 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
12/10/2002	US6492514 New compounds containing in the same molecule two functional groups, which can give rise to radicals by a photochemical process. the compounds are suitable as polymerisation photoinitiators in photopolymerisable formulations containing

1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 341